HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells.
TL;DR: Evidence is presented that PES-mediated inhibition of HSP70 family proteins in tumor cells results in an impairment of the two major protein degradation systems, namely, the autophagy-lysosome system and the proteasome pathway.
read more
Abstract: The evolutionarily conserved stress-inducible HSP70 molecular chaperone plays a central role in maintaining protein quality control in response to various forms of stress. Constitutively elevated HSP70 expression is a characteristic of many tumor cells and contributes to their survival. We recently identified the small-molecule 2-phenylethyenesulfonamide (PES) as a novel HSP70 inhibitor. Here we present evidence that PES-mediated inhibition of HSP70-family proteins in tumor cells results in an impairment of the two major protein degradation systems, namely the autophagy-lysosome system as well as the proteasome pathway. HSP70-family proteins work closely with the HSP90 molecular chaperone to maintain the stability and activities of their many client proteins and PES causes a disruption in the HSP70/HSP90 chaperone system. As a consequence, many cellular proteins, including known HSP70/HSP90 substrates, accumulate in detergent-insoluble cell fractions, indicative of aggregation and functional inactivation. Overall, PES simultaneously disrupts several cancer-critical survival pathways, supporting the idea of targeting HSP70 as a potential approach for cancer therapeutics.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand,Abhijit Dey,Arvind K. Singh Chandel,Rupa Sanyal,Amarnath Mishra,Devendra Kumar Pandey,Valentina De Falco,Arun Upadhyay,Ramesh Kandimalla,Anupama Chaudhary,Jaspreet Kaur Dhanjal,Saikat Dewanjee,Jayalakshmi Vallamkondu,José M. Pérez de la Lastra +13 more
TL;DR: In this paper , the authors reviewed the existing and contemporary advancements in chemotherapy and assessed the status of the enrolled drugs/pharmaceuticals; they also comprehensively discussed the emerging role of specific/targeted therapeutic strategies that are presently being employed to achieve better clinical success/survival rate in cancer patients.
625
The HSP70 family and cancer
TL;DR: The history, regulation, mechanism of action and role in cancer of the HSP70 family are reviewed, and the promise of pharmacologically targeting this protein for cancer therapy is addressed.
HSPA8/HSC70 chaperone protein: structure, function, and chemical targeting.
TL;DR: This review focused on HSC70 structure-function considerations and put a particular emphasis on H SC70 targeting by small molecules and peptides in order to develop intervention strategies that deviate some of HSC60 properties for therapeutic purposes.
372
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
Chen Hu,Jing Yang,Ziping Qi,Hong-ying Wu,Beilei Wang,Fengming Zou,Husheng Mei,Jing Liu,Wenchao Wang,Qingsong Liu +9 more
TL;DR: How the HSPs keep the protein proteostasis and response to stresses, and their roles in diseases and the recent exploration of HSP related therapy and diagnosis to modulate diseases are discussed.
311
Cotranslational Response to Proteotoxic Stress by Elongation Pausing of Ribosomes
TL;DR: It is reported that intracellular proteotoxic stress reduces global protein synthesis by halting ribosomes on transcripts during elongation, suggesting a dual role of molecular chaperones in facilitating polypeptide elongation and cotranslational folding.
282
References
The development of proteasome inhibitors as anticancer drugs
TL;DR: Efficacy and safety results from a phase 2 clinical trial contributed to approval of bortezomib for use in patients with relapsed and refractory multiple myeloma who have received at least 2 prior therapies and have demonstrated disease progression on their last therapy.
840
Structural Basis for Sorting Mechanism of p62 in Selective Autophagy
Yoshinobu Ichimura,Taichi Kumanomidou,Yu-shin Sou,Yu-shin Sou,Tsunehiro Mizushima,Junji Ezaki,Takashi Ueno,Eiki Kominami,Takashi Yamane,Keiji Tanaka,Masaaki Komatsu,Masaaki Komatsu,Masaaki Komatsu +12 more
TL;DR: In vivo analyses demonstrated that p62 mutants lacking LC3 binding ability accumulated without entrapping into autophagosomes in the cytoplasm and subsequently formed ubiquitin-positive inclusion bodies as in autophagy-deficient cells, demonstrating that the intracellular level of p62 is tightly regulated by Autophagy through the direct interaction of LC3 with p62.
804
Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
TL;DR: It is shown that autophagy inhibition increases levels of proteasome substrates, which will lead to increased levels of short-lived regulatory proteins, like p53, as well as the accumulation of aggregation-prone proteins, with predicted deleterious consequences.
685
Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization
Jesper Nylandsted,Mads Gyrd-Hansen,Agnieszka Danielewicz,Nicole Fehrenbacher,Ulrik Lademann,Maria Høyer-Hansen,Ekkehard Weber,Gabriele Multhoff,Mikkel Rohde,Marja Jäättelä +9 more
TL;DR: Data identify Hsp70 as the first survival protein that functions by inhibiting the death-associated permeabilization of lysosomes, and shows that it is physically associated with the membranes.
575
Molecular chaperones and the stress of oncogenesis.
TL;DR: It has been established that heat-shock proteins exhibit specificity to particular classes of polypeptide substrates and client proteins in vivo, and that chaperones can stabilize mutations that affect the folded conformation.
561
Related Papers (5)
Andrew Massey,Douglas S. Williamson,Helen Browne,James Brooke Murray,Pawel Dokurno,Terry Shaw,Macias Alba,Zoe Daniels,Stephanie Geoffroy,Melanie Dopson,Paul Lavan,Natalia Matassova,Geraint L. Francis,Christopher John Graham,Rachel Parsons,Yikang Wang,Antony Padfield,Mike Comer,Martin J. Drysdale,Michael Wood +19 more